Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
219.60    -0.40 (-0.18%)
Bid:
218.80
Ask:
219.00
Spread: 0.20 (0.091%)
Market Cap: £2.24b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Directorate Change

10 May 2024 07:00

RNS Number : 8892N
Helios Towers PLC
10 May 2024
 

10 May 2024

 

Helios Towers plc

 

Board Update - Director Changes

 

Helios Towers plc (the "Company") today announces that with effect from 9 May 2024, Helis Zulijani-Boye has resigned as a Non-Executive Director of the Company and has been replaced by David Wassong, Co-Managing Partner of Newlight Partners LP ("Newlight").

 

These changes are made pursuant to the Shareholders Agreement entered into by the Company and Newlight, along with other pre-IPO investors in the Company, under which Newlight is entitled to appoint (and replace) a shareholder representative as a director of the Company for such time as it continues to hold more than 10% of the voting rights of the Company.

 

Commenting on the changes to the Board, Sir Sam Jonah, Chairman of Helios Towers plc said today:

 

"On behalf of the Board, I would like to express my thanks to Helis for her contribution to the success of the business over the last two years. At the same time, we are delighted to welcome David to the Board. He brings extensive experience, which will enhance the Board, and we look forward to working with him going forward."

 

This announcement is made in accordance with Listing Rule ("LR") 9.6.11R. There are no further disclosures to be made pursuant to LR 9.6.13R in respect of David Wassong's appointment, except for LR 9.6.13R (1), whereby David Wassong was previously a Non-Executive Director of the Company from 12 September 2019 to 9 March 2022.

 

 

Enquiries:

 

For investor enquiries

investorrelations@heliostowers.com

 

 

For media enquiries

Edward Bridges, Rob Mindell

FTI Consulting LLP

+44 (0)20 3727 1000

 

About Helios Towers

· Helios Towers is a leading independent telecommunications infrastructure company, having established one of the most extensive tower portfolios across Africa and the Middle East. It builds, owns and operates telecom passive infrastructure, providing services to mobile network operators.

 

· Helios Towers owns and operates over 14,000 telecommunication tower sites in nine countries across Africa and the Middle East.

 

· Helios Towers pioneered the model in Africa of buying towers that were held by single operators and providing services utilising the tower infrastructure to the seller and other operators. This allows wireless operators to outsource non-core tower-related activities, enabling them to focus their capital and managerial resources on providing higher quality services more cost-effectively.

 

For more information about Helios Towers, please visit: https://www.heliostowers.com/investors/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALKLLBZELLBBX
Date   Source Headline
19th Jun 20247:00 amRNSRESULTS OF SECONDARY PLACING OF HELIOS TOWERS PLC
18th Jun 20245:05 pmRNSPROPOSED SECONDARY PLACING IN HELIOS TOWERS PLC
31st May 20244:35 pmRNSTender Results Announcement
23rd May 20247:00 amRNSBond Refinancing
20th May 20248:15 amRNSConditional Redemption of Senior Notes
20th May 20248:14 amRNSLaunch of Senior Notes
20th May 20248:14 amRNSOffer to Purchase 2025 Notes
16th May 20247:00 amRNSQ1 2024 Results
10th May 20247:00 amRNSDirectorate Change
3rd May 20247:00 amRNSBlock Listing Six Monthly Return
2nd May 20243:41 pmRNSDirector/PDMR Shareholding
25th Apr 20243:40 pmRNS2024 Annual General Meeting Results
23rd Apr 20247:00 amRNSNotice of Q1 2024 Results Date & Conference Call
22nd Apr 20247:00 amRNSCredit rating upgrade
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM
16th Mar 20237:00 amRNSFinal Results
27th Jan 20237:00 amRNSNotice of FY2022 Results Date & Conference Call
15th Dec 20225:56 pmRNSHolding in Company
8th Dec 20222:55 pmRNSClosing of tower acquisition in Oman
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.